![conference banner](/images/conference-banner.jpeg)
Abstract
The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process. Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the -form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e. IL-1β and TNF-α at the translational and transcriptional levels. Antagonism of these proinflammatory cytokines has been recognized as an effective possibility for the development of new drug candidates. The characterization of the pharmacological profile displayed by the selective p38 inhibitor prototype SB203580, proved its disease-modifying activity in the adjuvantinduced arthritis model. This strongly suggests that adequate modulation of production of these cytokines can bring significant benefits to the therapy of chronic inflammatory diseases. In addition to its important role for the secretion of proinflammatory cytokines, p38 is also involved in the activation of matrix metalloproteinases and the induction of COX- 2 transcription, proteins that are involved in the process of tissue destruction and inflammation. Because of its multiple functions in modulating the inflammatory response, it is expected that p38 inhibiting drugs will treat the underlying cause of chronic inflammatory diseases and stop their progression. The archetypal small molecule p38 inhibitors are the pyridinylimidazoles and these structures formed the basis for much of the early research. More recently a number of nonimidazole based p38 inhibitors such as the ureas, pyrazoles, pyrazoloheteroaryls, pyridazines, indoles, amides, pyridines, triazolopyridines, etc containing a variety of functionality have been reported to inhibit cytokine activity. This article provides a critical account of these different heterocycles reported for p38 MAPK inhibition and covers the recent research in the development of anti inflammatory agents.
Keywords: Anti inflammatory, Imidazole, p38 inhibitors, Kinases, Urea, Pyrazolyl urea.
Mini-Reviews in Medicinal Chemistry
Title:p38 MAP Kinase Inhibitors as Anti inflammatory Agents
Volume: 13 Issue: 14
Author(s): Mohammad Amir, K. Somakala and Sazid Ali
Affiliation:
Keywords: Anti inflammatory, Imidazole, p38 inhibitors, Kinases, Urea, Pyrazolyl urea.
Abstract: The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process. Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the -form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e. IL-1β and TNF-α at the translational and transcriptional levels. Antagonism of these proinflammatory cytokines has been recognized as an effective possibility for the development of new drug candidates. The characterization of the pharmacological profile displayed by the selective p38 inhibitor prototype SB203580, proved its disease-modifying activity in the adjuvantinduced arthritis model. This strongly suggests that adequate modulation of production of these cytokines can bring significant benefits to the therapy of chronic inflammatory diseases. In addition to its important role for the secretion of proinflammatory cytokines, p38 is also involved in the activation of matrix metalloproteinases and the induction of COX- 2 transcription, proteins that are involved in the process of tissue destruction and inflammation. Because of its multiple functions in modulating the inflammatory response, it is expected that p38 inhibiting drugs will treat the underlying cause of chronic inflammatory diseases and stop their progression. The archetypal small molecule p38 inhibitors are the pyridinylimidazoles and these structures formed the basis for much of the early research. More recently a number of nonimidazole based p38 inhibitors such as the ureas, pyrazoles, pyrazoloheteroaryls, pyridazines, indoles, amides, pyridines, triazolopyridines, etc containing a variety of functionality have been reported to inhibit cytokine activity. This article provides a critical account of these different heterocycles reported for p38 MAPK inhibition and covers the recent research in the development of anti inflammatory agents.
Export Options
About this article
Cite this article as:
Amir Mohammad, Somakala K. and Ali Sazid, p38 MAP Kinase Inhibitors as Anti inflammatory Agents, Mini-Reviews in Medicinal Chemistry 2013; 13 (14) . https://dx.doi.org/10.2174/13895575113136660098
DOI https://dx.doi.org/10.2174/13895575113136660098 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer’s, Parkinson’s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
OMICS-Derived Targets for Inflammatory Gut Disorders: Opportunities for the Development of Nutrition Related Biomarkers
Endocrine, Metabolic & Immune Disorders - Drug Targets In vitro and in silico Studies of Mangiferin from Aphloia theiformis on Key Enzymes Linked to Diabetes Type 2 and Associated Complications
Medicinal Chemistry Mechanisms of Interferon Mediated Anti-Viral Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
Current Drug Safety The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
Current Medicinal Chemistry Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction Pathways
Current Drug Metabolism Synthetic Strategies for Quinoline Based Derivatives as Potential Bioactive Heterocycles
Current Organic Synthesis Contemporary Progress in the Synthetic Strategies of Imidazole and its Biological Activities
Current Organic Synthesis Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews Do Adult Stem Cells Ameliorate the Damaged Myocardium? Human Cord Blood as a Potential Source of Stem Cells
Current Vascular Pharmacology New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative Colitis
Current Pharmaceutical Design Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology Diagnostic Strategy for Suspected Unilateral Absence of the Pulmonary Artery
Current Medical Imaging Fenofibrate: A New Treatment for Diabetic Retinopathy. Molecular Mechanisms and Future Perspectives
Current Medicinal Chemistry Phytochemical Analysis, Antibacterial and Antioxidant Activity of Calotropis procera and Calotropis gigantea
The Natural Products Journal Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker
Medicinal Chemistry Role of Angiopoietin-like 4 (ANGPTL4), a Member of Matricellular Proteins: from Homeostasis to Inflammation and Cancer Metastasis
Current Angiogenesis (Discontinued) Targeting the Toll-System in Cardiovascular Sciences
Recent Patents on Inflammation & Allergy Drug Discovery Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells
Current Drug Targets